Dr. Saeed R. Shaikh, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 475
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
IN license 01057418A -
Cardiovascular Disease Physician
IN license 01057418A -
Nuclear Cardiology Physician
IN license 01057418A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Franciscan Health Indianapolis Indianapolis, IN
- Franciscan Health Lafayette Lafayette, IN
- Franciscan Health Mooresville Mooresville, IN
- Major Hospital Shelbyville, IN
- Franciscan Health Crawfordsville Crawfordsville, IN
Medical groups
- Franciscan Physician Network (1,170 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 475
- Services billed
- 1,176
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 146 | 127 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 109 | 98 |
| Established patient office or other outpatient visit, 40-54 minutes | 100 | 92 |
| Repair of left upper heart chamber with implant with review by radiologist | 80 | 80 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 76 | 74 |
| Ct scan of heart structure with contrast | 73 | 65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | 64 |
| Replacement of aortic valve through the skin and femoral artery | 52 | 52 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 41 | 41 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 14 payments worth $1,566 in total to this clinician.
| Abbott Laboratories | $1,488 |
|---|---|
| Edwards Lifesciences Corporation | $39.52 |
| Terumo Medical Corporation | $39.27 |
| Travel and Lodging | $1,147 |
|---|---|
| Food and Beverage | $420 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Nov 14, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Minneapolis, MN · in-kind | $892 |
| Abbott Laboratories Oct 15, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Minneapolis, MN · in-kind | $246 |
| Abbott Laboratories Nov 14, 2025 | Travel and Lodging TRICLIP · Structural Heart · travel to Minneapolis, MN · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $81,949 in research payments for these studies, mostly to the institutions running them.
- Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Novartis Pharmaceuticals Corporation - A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a)
Amgen Inc. - CHAMPION-AF Clinical Trial
Boston Scientific Corporation · Active, not recruiting · NCT04394546
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.